 | Up a level |
Krenger, Pascal S; Josi, Romano; Sobczak, Jan; Velazquez, Thalia L C; Balke, Ina; Skinner, Murray A; Kramer, Matthias F; Scott, Callum J W; Hewings, Simon; Heath, Matthew D; Zeltins, Andris; Bachmann, Martin F (2024). Influence of antigen density and TLR ligands on preclinical efficacy of a VLP-based vaccine against peanut allergy. Allergy, 79(1), pp. 184-199. Wiley 10.1111/all.15897
Krenger, Pascal S; Sobczak, Jan; Paolucci, Marta; Kündig, Thomas M; Johansen, Pål; Vogel, Monique; Bachmann, Martin F (2023). BALB/c and C3H mice are both suitable as peanut allergy models. Clinical and experimental allergy, 53(12), pp. 1310-1313. Wiley 10.1111/cea.14398
Sobczak, Jan M; Krenger, Pascal S; Storni, Federico; Mohsen, Mona O; Balke, Ina; Reseviča, Gunta; Heath, Matthew D; Carreno Velazquez, Thalia L; Kramer, Matthias F; Scott, Callum J W; Skinner, Murray A; Zeltiņš, Andris; Kündig, Thomas M; Vogel, Monique; Bachmann, Martin F (2023). The next generation virus-like particle platform for the treatment of peanut allergy. Allergy, 78(7), pp. 1980-1996. Wiley-Blackwell 10.1111/all.15704
Mohsen, Mona O.; Balke, Ina; Zinkhan, Simon; Zeltina, Villija; Liu, Xuelan; Chang, Xinyue; Krenger, Pascal S.; Plattner, Kevin; Gharailoo, Zahra; Vogt, Anne-Cathrine S.; Augusto, Gilles; Zwicker, Marianne; Roongta, Salony; Rothen, Dominik A.; Josi, Romano; J. Da Costa, Joana; Sobczak, Jan M.; Nonic, Aleksandra; Brand, Lee-Anne; Nuss, Katja; ... (2022). A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2. Allergy, 77(1), pp. 243-257. Wiley 10.1111/all.15080
Peterhoff, David; Thalhauser, Stefanie; Sobczak, Jan M.; Mohsen, Mona O.; Voigt, Christoph; Seifert, Nicole; Neckermann, Patrick; Hauser, Alexandra; Ding, Song; Sattentau, Quentin; Bachmann, Martin F.; Breunig, Miriam; Wagner, Ralf (2021). Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery. Vaccines, 9(6) MDPI 10.3390/vaccines9060642
